UKB NewsRoom | Annkristin Heine
Prolonged IKKβ Inhibition Improves Ongoing CTL Antitumor Responses by Incapacitating Regulatory T Cells - ScienceDirect
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Team | IMMEI
Annkristin HEINE - Medical Doctor - University of Bonn - Medical Center, Bonn - Haematology Oncology
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
AG Heine - Hämatologie und Onkologie der Universitätsklinikum Bonn
Detection of Damaged DNA Bases by DNA Glycosylase Enzymes | Biochemistry
Medicine®
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imagin
Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products - Cytotherapy
RNA Vaccines in Cancer Treatment – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Cardiac MRI in Suspected Acute COVID-19 Myocarditis | Radiology: Cardiothoracic Imaging
CIO Bonn - Lymphomzentrum
Clinical Case Reports: Vol 9, No 9
Implementing combinatorial immunotherapeutic regimens against cancer
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
PDF) Clinical and immunological effects of mRNA vaccines in malignant diseases
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
Advances in Immunotherapy of Chronic Myeloid Leukemia CML
Erfolg bei Ausschreibung? Advanced Clinician Scientist? – Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
S. Heine, Ann-Kristin Hedmark & Bosse Broberg - Wanderer | Play on Anghami
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient. - Abstract - Europe PMC
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie der Universitätsklinikum Bonn
